申请人:COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
公开号:US20140235654A1
公开(公告)日:2014-08-21
The present invention relates to the use of derivatives of indoles having a general formula (I) as follow:
for the manufacture of a pharmaceutical composition intended for the treatment of cancer.
本发明涉及使用具有以下一般式(I)的
吲哚衍
生物的制备,用于制造用于治疗癌症的药物组合物。